Navidea Biopharmaceuticals, Inc., a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, announced the promotion of Michael Sherman Blue, M.D., FACEP to the position of Chief Medical Officer, reporting directly to the Company’s Board of Directors.
May 11, 2023
· 7 min read